Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,029 | 535 | 99.9% |
| Education | $5.11 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,026 | 69 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,003 | 61 | $0 (2024) |
| Lilly USA, LLC | $862.11 | 71 | $0 (2024) |
| Amgen Inc. | $568.54 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $544.00 | 43 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $522.40 | 33 | $0 (2020) |
| PFIZER INC. | $522.19 | 42 | $0 (2024) |
| ABBVIE INC. | $445.77 | 35 | $0 (2024) |
| Dexcom, Inc. | $304.30 | 8 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $192.36 | 11 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,776 | 98 | Lilly USA, LLC ($266.18) |
| 2023 | $857.08 | 52 | ABBVIE INC. ($142.97) |
| 2022 | $590.26 | 34 | Biohaven Pharmaceutical Holding Company Ltd. ($104.44) |
| 2020 | $325.72 | 23 | AstraZeneca Pharmaceuticals LP ($71.07) |
| 2019 | $1,324 | 94 | AstraZeneca Pharmaceuticals LP ($212.74) |
| 2018 | $1,375 | 101 | Novo Nordisk Inc ($238.88) |
| 2017 | $1,787 | 134 | SANOFI-AVENTIS U.S. LLC ($302.27) |
All Payment Transactions
536 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $10.01 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Hepatitis B Vaccine | ||||||
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $49.55 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: PAIN | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Hematology | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $40.85 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,373 | 3,551 | $461,155 | $184,318 |
| 2022 | 25 | 2,710 | 5,229 | $500,477 | $167,973 |
| 2021 | 30 | 2,236 | 4,515 | $527,497 | $167,178 |
| 2020 | 25 | 1,987 | 3,239 | $484,437 | $142,179 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 461 | 915 | $219,600 | $71,884 | 32.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 162 | 162 | $49,248 | $25,706 | 52.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 75 | 76 | $39,292 | $20,588 | 52.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 204 | 286 | $47,190 | $15,597 | 33.1% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 99 | 99 | $13,860 | $12,591 | 90.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 141 | 145 | $20,880 | $10,324 | 49.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 456 | 874 | $6,118 | $5,903 | 96.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 148 | 152 | $4,864 | $4,368 | 89.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 99 | 99 | $7,920 | $3,780 | 47.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 173 | 343 | $15,092 | $3,219 | 21.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 82 | 83 | $3,403 | $2,372 | 69.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $11,284 | $2,281 | 20.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $3,312 | $1,981 | 59.8% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 32 | 32 | $2,784 | $1,234 | 44.3% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 19 | 19 | $3,781 | $776.10 | 20.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 16 | $2,832 | $613.48 | 21.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 65 | 66 | $5,742 | $526.88 | 9.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 33 | $1,914 | $344.00 | 18.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 12 | 27 | $1,237 | $85.68 | 6.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 16 | $250.88 | $79.46 | 31.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 29 | $551.00 | $63.81 | 11.6% |
| 91312 | Sarscov2 vac bvl 30mcg/0.3ml | Office | 2023 | 32 | 32 | $0.32 | $0.32 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 458 | 975 | $234,000 | $75,219 | 32.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 1,140 | $52,987 | $17,929 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 189 | 278 | $45,870 | $15,814 | 34.5% |
About Dr. Gregory Hooks, MD
Dr. Gregory Hooks, MD is a Internal Medicine healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629037320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Hooks, MD has received a total of $8,034 in payments from pharmaceutical and medical device companies, with $1,776 received in 2024. These payments were reported across 536 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,029).
As a Medicare-enrolled provider, Hooks has provided services to 9,306 Medicare beneficiaries, totaling 16,534 services with total Medicare billing of $661,648. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Columbia, SC
- Active Since 03/21/2006
- Last Updated 04/17/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1629037320
Products in Payments
- FARXIGA (Drug) $693.88
- JARDIANCE (Drug) $443.93
- Dexcom G6 Transmitter (Medical Supply) $304.30
- MOUNJARO (Drug) $269.93
- Victoza (Drug) $249.33
- Ozempic (Drug) $248.35
- TRULICITY (Drug) $228.40
- SOLIQUA (Drug) $202.34
- Otezla (Drug) $198.19
- CHANTIX (Drug) $196.54
- TROKENDI XR (Drug) $192.36
- VRAYLAR (Drug) $186.45
- Rybelsus (Drug) $166.87
- NURTEC ODT (Drug) $162.35
- EMGALITY (Drug) $157.05
- Prolia (Biological) $151.66
- Aimovig (Biological) $148.30
- BYDUREON (Drug) $136.66
- XIFAXAN (Drug) $134.03
- Tresiba (Drug) $133.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Columbia
Dr. Mark Corriere, M.d, M.D
Internal Medicine — Payments: $499,000
Dr. David Nyanjom, M.d, M.D
Internal Medicine — Payments: $191,423
Dr. David Amrol, M.d, M.D
Internal Medicine — Payments: $144,633
Jake Krieg, M.d, M.D
Internal Medicine — Payments: $96,198
Donald Delwood, M.d, M.D
Internal Medicine — Payments: $72,250
Loren Morgan, Md, MD
Internal Medicine — Payments: $41,678